speb/financial-data huggingface dataset:
Financial ratios for ABMINTLLTD.NS — annual report dated 2023-03-31
Total revenue: 10398294.762484776
Gross profit: -993422.6552984166
Operating income: -1181473.8124238735
Net income: -815956.1510353228
Capital expenditures: 1218.026796589525
Operating cash flow: -1428745.432399513
Depreciation & amortization: 6090.133982947626
Net tangible assets: 2216114.49451888
Owner earnings: -811084.0438489646
Return on net tangible assets (%): -36.59937452938557
Buffett classification: The Gruesome
Stock price: 0.6693057247259441
Shares outstanding: 9408000
Book value: 2216114.4945188793
P/B ratio: 2.841382191125793
Market cap (USD): 6296828.258221682
Debt to equity: 0
Current ratio: 1.6559643455372097
Quick ratio: 0.8502392916965781
Interest coverage ratio: -969.9900000000001
COGS to revenue (%): 109.55370739135526
SG&A to revenue (%): 0.20358439732927258
Free cash flow (dilution-adjusted): -1429963.4591961023
Buyback yield (%): 0
Retained earnings: 519342.2655298417
Inventory turnover: 6.944054646025912
Receivables turnover: 29.357955913201966
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -52.54294211008131
FCF margin (%): -13.751903478973876
Revenue growth (%): -37.906035509655396
Rule of 40 score: -51.65793898862927
Financial ratios for ABMINTLLTD.NS — annual report dated 2024-03-31
Total revenue: 11229607.866650678
Gross profit: -403021.9450773474
Operating income: -540712.3156253748
Net income: -409581.4845904785
Capital expenditures: 0
Operating cash flow: -1153147.85945557
Depreciation & amortization: 4676.819762561458
Net tangible assets: 1781256.745413119
Owner earnings: -404904.664827917
Return on net tangible assets (%): -22.731403873730134
Buffett classification: The Gruesome
Stock price: 0.7299664107485605
Shares outstanding: 9408000
Book value: 1781256.745413119
P/B ratio: 3.8554374657145245
Market cap (USD): 6867523.992322457
Debt to equity: 0.6764688061721165
Current ratio: 1.2695088029048753
Quick ratio: 0.6817754051668139
Interest coverage ratio: -10.031145717463849
COGS to revenue (%): 103.58892269314433
SG&A to revenue (%): 0.1914704352775467
Free cash flow (dilution-adjusted): -1153147.85945557
Buyback yield (%): 0
Retained earnings: 102254.46696246552
Inventory turnover: 6.872781505281877
Receivables turnover: 19.414861194617792
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -29.79581048040706
FCF margin (%): -10.268816802411692
Revenue growth (%): 7.994706085512543
Rule of 40 score: -2.2741107168991492
Financial ratios for ABMINTLLTD.NS — quarterly report dated 2024-09-30
Total revenue: 1995090.778786431
Gross profit: -37828.475871954135
Operating income: -70914.95461060679
Net income: -60355.94839942666
Capital expenditures: 0
Depreciation & amortization: 1194.4577161968466
Owner earnings: -59161.490683229815
Buffett classification: The Gruesome
Stock price: 0.6796464405160058
Shares outstanding: 9408000
Market cap (USD): 6394113.712374582
Interest coverage ratio: -32.09189189189189
COGS to revenue (%): 101.8960779265876
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ABMINTLLTD.NS — quarterly report dated 2024-12-31
Total revenue: 1944527.3341881337
Gross profit: -210991.95710455763
Operating income: -241380.114232428
Net income: -240074.60076932042
Capital expenditures: 0
Depreciation & amortization: 1165.6370206317752
Owner earnings: -238908.96374868863
Buffett classification: The Gruesome
Stock price: 0.8072036367875043
Shares outstanding: 9408000
Market cap (USD): 7594171.814896841
Interest coverage ratio: -21.260780287474333
COGS to revenue (%): 110.85055238848824
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -2.5343931782920657
Rule of 40 score: -2.5343931782920657
Financial ratios for ABMINTLLTD.NS — annual report dated 2025-03-31
Total revenue: 9374935.702595277
Gross profit: -123778.3493102642
Operating income: -253191.48936170212
Net income: -159504.32546177227
Capital expenditures: 1017.068038344634
Operating cash flow: -143429.9742810381
Depreciation & amortization: 3577.2737900397474
Net tangible assets: 1581470.6570025717
Owner earnings: -156944.11971007718
Return on net tangible assets (%): -9.92393497882155
Buffett classification: The Gruesome
Stock price: 0.4887384759015055
Shares outstanding: 9408000
Book value: 1581470.657002572
P/B ratio: 2.9074529842976946
Market cap (USD): 4598051.581281364
Debt to equity: 1.0830062315658748
Current ratio: 1.199910425521836
Quick ratio: 0.7721406147048565
Interest coverage ratio: -10.684755796743957
COGS to revenue (%): 101.32031144785343
Free cash flow (dilution-adjusted): -144447.04231938274
Buyback yield (%): 0
Inventory turnover: 8.179841340152217
Receivables turnover: 22.28889074182162
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -15.694771549693828
FCF margin (%): -1.5407790186699122
Revenue growth (%): -16.515912096657857
Rule of 40 score: -18.05669111532777
Financial ratios for ABMINTLLTD.NS — quarterly report dated 2025-03-31
Total revenue: 2065969.1372457328
Gross profit: -254547.58007949495
Operating income: -280324.9941547814
Net income: -203179.79892447975
Capital expenditures: 0
Depreciation & amortization: 70.14262333411268
Net tangible assets: 1581470.6570025717
Owner earnings: -203109.65630114565
Return on net tangible assets (%): -12.843087249314381
Buffett classification: The Gruesome
Stock price: 0.4887384759015055
Shares outstanding: 9408000
Book value: 1581470.657002572
P/B ratio: 2.9074529842976946
Market cap (USD): 4598051.581281364
Debt to equity: 1.0830062315658748
Current ratio: 1.199910425521836
Quick ratio: 0.7721406147048565
Interest coverage ratio: -82.68620689655174
COGS to revenue (%): 112.32097689604636
Buyback yield (%): 0
Inventory turnover: 1.9983187693794549
Receivables turnover: 4.911837460740988
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -17.376716547701005
Revenue growth (%): 6.245312211479027
Rule of 40 score: 6.245312211479027
Financial ratios for ACNT — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 16.43
Shares outstanding: 9038215
Market cap (USD): 148497872.45
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ACNT — annual report dated 2022-12-31
Total revenue: 261993000
Gross profit: 43287000
Operating income: 15647000
Net income: 22066000
Capital expenditures: 3295000
Operating cash flow: 5577000
Depreciation & amortization: 8274000
Net tangible assets: 112869000
Owner earnings: 27045000
Return on net tangible assets (%): 23.96140658639662
Capex to operating income (%): 21.058349843420466
Buffett classification: The Great
Stock price: 8.67
P/E ratio: 3.55122469183359
Shares outstanding: 9038215
Book value: 134259000
P/B ratio: 0.5836578855048824
Market cap (USD): 78361324.05
Debt to equity: 0.7846177909860792
Current ratio: 5.089163032439214
Quick ratio: 3.067805723161479
Effective tax rate (%): -46.36136552872606
Interest coverage ratio: 5.706418672501823
COGS to revenue (%): 83.47780284206067
SG&A to revenue (%): 10.549900188172966
Free cash flow (dilution-adjusted): 828000
Buyback yield (%): 1.7138556759748882
Retained earnings: 85146000
Inventory turnover: 3.2319014053287227
Receivables turnover: 7.890880067465815
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.6423280198671275
FCF margin (%): 0.31603897814063736
Rule of 40 score: 0.31603897814063736
Financial ratios for ACNT — annual report dated 2023-12-31
Total revenue: 193179000
Gross profit: 1526000
Operating income: -25186000
Net income: -26629000
Capital expenditures: 2885000
Operating cash flow: 23078000
Depreciation & amortization: 7666000
Net tangible assets: 98914000
Owner earnings: -21848000
Return on net tangible assets (%): -22.08787431506157
Buffett classification: The Gruesome
Stock price: 9.56
Shares outstanding: 9038215
Book value: 107410000
P/B ratio: 0.8044440499022438
Market cap (USD): 86405335.4
Debt to equity: 0.3056326226608323
Current ratio: 3.60696276574287
Quick ratio: 1.4969139537698173
Interest coverage ratio: -5.942897593204342
COGS to revenue (%): 99.21005906439106
SG&A to revenue (%): 13.82758995542994
Free cash flow (dilution-adjusted): 19170000
Buyback yield (%): 1.4894913537943397
Retained earnings: 58517000
Inventory turnover: 3.6640729553014952
Receivables turnover: 7.26127649977447
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -18.184049788456818
FCF margin (%): 9.923438883108412
Revenue growth (%): -26.265587248514272
Rule of 40 score: -16.342148365405862
Financial ratios for ACNT — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 9.7
Shares outstanding: 9038215
Market cap (USD): 87670685.5
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ACNT — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 11.18
Shares outstanding: 9038215
Market cap (USD): 101047243.7
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ACNT — annual report dated 2024-12-31
Total revenue: 80763000
Gross profit: 10692000
Operating income: -10207000
Net income: -13598000
Capital expenditures: 1120000
Operating cash flow: 14681000
Depreciation & amortization: 4579000
Net tangible assets: 90100000
Owner earnings: -10139000
Return on net tangible assets (%): -11.25305216426193
Buffett classification: The Gruesome
Stock price: 11.18
Shares outstanding: 9038215
Book value: 93545000
P/B ratio: 1.0801993019402425
Market cap (USD): 101047243.7
Debt to equity: 0.35431075952750013
Current ratio: 3.717366984382691
Quick ratio: 3.4610909741799794
Interest coverage ratio: -24.41866028708134
COGS to revenue (%): 86.76126444039969
SG&A to revenue (%): 25.87694860270173
Free cash flow (dilution-adjusted): 12801000
Buyback yield (%): 1.0262526339449276
Retained earnings: 44919000
Inventory turnover: 12.235201676270298
Receivables turnover: 6.574649951155975
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -8.171941426547
FCF margin (%): 15.85007986330374
Revenue growth (%): -58.19266069293246
Rule of 40 score: -42.34258082962872
Financial ratios for ACNT — quarterly report dated 2025-03-31
Total revenue: 17835000
Gross profit: 3068000
Operating income: -1803000
Net income: -2293000
Capital expenditures: 318000
Operating cash flow: -700000
Depreciation & amortization: 1130000
Net tangible assets: 84478000
Owner earnings: -1481000
Return on net tangible assets (%): -1.753119155283032
Buffett classification: The Gruesome
Stock price: 12.66
Shares outstanding: 9038215
Book value: 91156000
P/B ratio: 1.2552525549607265
Market cap (USD): 114423801.9
Debt to equity: 0.357299574356049
Current ratio: 2.9517005234912586
Quick ratio: 2.6000395087742403
Interest coverage ratio: -15.81578947368421
COGS to revenue (%): 82.79786935800392
R&D to revenue (%): 0
SG&A to revenue (%): 27.311466218110457
Free cash flow (dilution-adjusted): -1136000
Buyback yield (%): 0.18789796915496476
Retained earnings: 42626000
Inventory turnover: 1.3825484505196142
Receivables turnover: 1.0369186046511627
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.4758244726567296
FCF margin (%): -6.3694981777403985
Rule of 40 score: -6.3694981777403985
Financial ratios for ACNT — quarterly report dated 2025-06-30
Total revenue: 18652000
Gross profit: 4866000
Operating income: -1578000
Net income: 6286000
Capital expenditures: 148000
Operating cash flow: -1396000
Depreciation & amortization: 1046000
Net tangible assets: 86577000
Owner earnings: 7184000
Return on net tangible assets (%): 8.297815817133882
Buffett classification: The Gruesome
Stock price: 12.61
P/E ratio: 28.542922902579512
Shares outstanding: 9038215
Book value: 89716000
P/B ratio: 1.2703630472825358
Market cap (USD): 113971891.14999999
Debt to equity: 0.2461768246466628
Current ratio: 6.643556031187892
Quick ratio: 6.134000917290934
COGS to revenue (%): 73.91164486382158
SG&A to revenue (%): 34.54857387947673
Free cash flow (dilution-adjusted): -1648000
Buyback yield (%): 6.869237599730747
Retained earnings: 48912000
Inventory turnover: 2.0681068106810683
Receivables turnover: 1.0539639486918686
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -1.44112221227785
FCF margin (%): -8.83551361784259
Revenue growth (%): 4.580880291561536
Rule of 40 score: -4.254633326281054
Financial ratios for ACNT — quarterly report dated 2025-09-30
Total revenue: 19697000
Gross profit: 5841000
Operating income: -412000
Net income: -2087000
Capital expenditures: 616000
Operating cash flow: 1311000
Depreciation & amortization: 1007000
Net tangible assets: 84102000
Owner earnings: -1696000
Return on net tangible assets (%): -2.0165988918218356
Buffett classification: The Gruesome
Stock price: 12.88
P/E ratio: 61.07670996852046
Shares outstanding: 9038215
Book value: 87088000
P/B ratio: 1.3367192862392063
Market cap (USD): 116412209.2
Debt to equity: 0.24625665993018556
Current ratio: 6.4033645141822575
Quick ratio: 5.861873868436934
COGS to revenue (%): 70.34573792963396
SG&A to revenue (%): 31.745951160075137
Free cash flow (dilution-adjusted): 405000
Buyback yield (%): 0.7138426507930234
Retained earnings: 46825000
Inventory turnover: 1.9303427138478686
Receivables turnover: 1.0954340692953672
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.3863719486462915
FCF margin (%): 2.0561506828451033
Revenue growth (%): 5.6026163414111085
Rule of 40 score: 7.658767024256212
Financial ratios for ACNT — annual report dated 2025-12-31
Total revenue: 74942000
Gross profit: 17212000
Operating income: -6952000
Net income: 867000
Capital expenditures: 1544000
Operating cash flow: -519000
Depreciation & amortization: 4186000
Net tangible assets: 84159000
Owner earnings: 3509000
Return on net tangible assets (%): 4.169488705901924
Buffett classification: The Gruesome
Stock price: 16.19
P/E ratio: 168.77589486735872
Shares outstanding: 9038215
Book value: 86992000
P/B ratio: 1.6820937655186685
Market cap (USD): 146328700.85000002
Debt to equity: 0.15840537060879162
Current ratio: 6.719546742209632
Quick ratio: 6.0119789558883046
COGS to revenue (%): 77.03290544687891
R&D to revenue (%): 0.09473993221424569
SG&A to revenue (%): 32.14886178644819
Free cash flow (dilution-adjusted): -3365000
Buyback yield (%): 6.244161225326699
Retained earnings: 45786000
Inventory turnover: 6.6037520018302445
Receivables turnover: 4.857216929159375
Capitalized R&D asset: 71000
ROCI (R&D-adjusted, %): -6.928709287895665
FCF margin (%): -4.4901390408582635
Revenue growth (%): -7.2075083887423705
Rule of 40 score: -11.697647429600634
Financial ratios for ACNT — quarterly report dated 2025-12-31
Total revenue: 18759000
Gross profit: 3439000
Operating income: -3158000
Net income: -1039000
Capital expenditures: 462000
Operating cash flow: 266000
Depreciation & amortization: 1003000
Net tangible assets: 84159000
Owner earnings: -498000
Return on net tangible assets (%): -0.5917370691191673
Buffett classification: The Gruesome
Stock price: 16.19
P/E ratio: 168.77589486735872
Shares outstanding: 9038215
Book value: 86992000
P/B ratio: 1.6820937655186685
Market cap (USD): 146328700.85000002
Debt to equity: 0.15840537060879162
Current ratio: 6.719546742209632
Quick ratio: 6.0119789558883046
COGS to revenue (%): 81.6674662828509
SG&A to revenue (%): 34.78863478863479
Free cash flow (dilution-adjusted): -986000
Buyback yield (%): 0.17904894834580223
Retained earnings: 45786000
Inventory turnover: 1.7524593914436055
Receivables turnover: 1.2158273381294964
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -3.171255849450704
FCF margin (%): -5.256143717682179
Revenue growth (%): -4.762146519774585
Rule of 40 score: -10.018290237456764
Financial ratios for ADN1.DE — annual report dated 2021-12-31
Total revenue: 770822727.2727273
Gross profit: 231552272.72727272
Operating income: 54510227.27272727
Net income: 54064772.72727273
Capital expenditures: 19068181.818181816
Operating cash flow: 54445454.54545455
Depreciation & amortization: 40906818.18181818
Net tangible assets: 106857954.54545455
Owner earnings: 75903409.0909091
Return on net tangible assets (%): 71.03206252990908
Capex to operating income (%): 34.980925180845965
Buffett classification: The Good
Stock price: 228.63636363636363
P/E ratio: 27.095326624209175
Shares outstanding: 6407129
Book value: 210929545.45454544
P/B ratio: 6.9449856953528215
Market cap (USD): 1464902675.9090908
Debt to equity: 1.0644064692001853
Current ratio: 1.5824224849431183
Quick ratio: 1.5824224849431183
Effective tax rate (%): 24.755653961727024
Interest coverage ratio: 17.753145817912657
COGS to revenue (%): 69.96037291913598
SG&A to revenue (%): 1.7478373166805246
Free cash flow (dilution-adjusted): 33581818.18181818
Buyback yield (%): 0
Retained earnings: 143506818.1818182
Receivables turnover: 5.652699999999999
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 12.694140779024195
FCF margin (%): 4.356620140227974
Rule of 40 score: 4.356620140227974
Financial ratios for ADN1.DE — annual report dated 2022-12-31
Total revenue: 957715957.4468086
Gross profit: 286717021.2765958
Operating income: 41371276.595744684
Net income: 30630851.06382979
Capital expenditures: 19712765.95744681
Operating cash flow: 38374468.08510639
Depreciation & amortization: 47615957.44680852
Net tangible assets: 90790425.5319149
Owner earnings: 58534042.5531915
Return on net tangible assets (%): 64.47160282624233
Capex to operating income (%): 47.648435290184885
Buffett classification: The Good
Stock price: 135.43617021276597
P/E ratio: 28.32951040148647
Shares outstanding: 6407129
Book value: 228915957.44680858
P/B ratio: 3.7907231260659624
Market cap (USD): 867757013.819149
Debt to equity: 0.6387878111915084
Current ratio: 1.5838862957039137
Quick ratio: 1.5838862957039137
Effective tax rate (%): 31.578822299320375
Interest coverage ratio: 8.617106137824063
COGS to revenue (%): 70.06241578756193
SG&A to revenue (%): 2.7425623685786107
Free cash flow (dilution-adjusted): 12892553.191489363
Buyback yield (%): 0
Retained earnings: 165546808.5106383
Receivables turnover: 5.226432510885341
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.816088358111509
FCF margin (%): 1.3461771302067307
Revenue growth (%): 24.24594184389636
Rule of 40 score: 25.59211897410309
Financial ratios for ADN1.DE — annual report dated 2023-12-31
Total revenue: 1262114444.4444444
Gross profit: 360150000
Operating income: 19825555.555555556
Net income: 3788888.888888889
Capital expenditures: 29165555.555555556
Operating cash flow: 85400000
Depreciation & amortization: 64136666.666666664
Net tangible assets: 59313333.33333333
Owner earnings: 38760000
Return on net tangible assets (%): 65.34787006856244
Capex to operating income (%): 147.110911842179
Buffett classification: The Gruesome
Stock price: 115.97777777777777
P/E ratio: 196.12203079765393
Shares outstanding: 6407129
Book value: 221325555.55555558
P/B ratio: 3.3574278464604674
Market cap (USD): 743084583.3555555
Debt to equity: 0.8977373702891164
Current ratio: 1.3798790760093653
Quick ratio: 1.3798790760093653
Effective tax rate (%): 72.03313376527515
Interest coverage ratio: 1.5826680858612738
COGS to revenue (%): 71.46455287115185
SG&A to revenue (%): 1.8844038619494796
Free cash flow (dilution-adjusted): 47238888.88888889
Buyback yield (%): 0
Retained earnings: 159802222.2222222
Receivables turnover: 6.244896724997664
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.557933315918875
FCF margin (%): 3.7428371964859672
Revenue growth (%): 31.783796085964468
Rule of 40 score: 35.52663328245043
Financial ratios for ADN1.DE — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 74.05555555555556
Shares outstanding: 6407129
Market cap (USD): 474483497.6111111
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for ADN1.DE — annual report dated 2024-12-31
Total revenue: 1339526041.6666667
Gross profit: 377538541.6666667
Operating income: 26475000
Net income: 4325000
Capital expenditures: 38121875
Operating cash flow: 122934375
Net tangible assets: 27055208.333333336
Owner earnings: -33796875
Return on net tangible assets (%): -124.9181842682786
Capex to operating income (%): 143.99197355996222
Buffett classification: The Gruesome
Stock price: 89.71875
P/E ratio: 132.91089132225434
Shares outstanding: 6407129
Book value: 186743750
P/B ratio: 3.0782267410221222
Market cap (USD): 574839604.96875
Debt to equity: 0
Current ratio: 1.0873275447509985
Quick ratio: 1.0873275447509985
Effective tax rate (%): 69.1140370453024
COGS to revenue (%): 71.81551310514836
Free cash flow (dilution-adjusted): 84812500
Buyback yield (%): 0
Retained earnings: 141373958.33333334
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.549248048069028
FCF margin (%): 6.331530508692051
Revenue growth (%): 6.133484769386127
Rule of 40 score: 12.465015278078178
Financial ratios for ADN1.DE — quarterly report dated 2024-12-31
Total revenue: 349680208.3333334
Gross profit: 207646875
Operating income: 11140625
Net income: 8071875
Capital expenditures: 3869791.666666667
Operating cash flow: 97439583.33333334
Depreciation & amortization: 19322916.666666668
Owner earnings: 23525000
Capex to operating income (%): 34.73585787751286
Buffett classification: The Good
Stock price: 89.71875
P/E ratio: 17.803781803135887
Shares outstanding: 6407129
Market cap (USD): 574839604.96875
Effective tax rate (%): 20.08868722285243
Interest coverage ratio: 2.5082082551594747
COGS to revenue (%): 40.61806471984819
Free cash flow (dilution-adjusted): 89169791.66666667
Buyback yield (%): 1.4822975417284534
Capitalized R&D asset: 0
FCF margin (%): 25.500382790227977
Rule of 40 score: 25.500382790227977
Financial ratios for ADN1.DE — quarterly report dated 2025-03-31
Total revenue: 381792391.3043478
Gross profit: 57945652.17391304
Operating income: 184782.60869565216
Net income: -7164130.434782608
Capital expenditures: 5232608.695652174
Operating cash flow: -44995652.17391304
Depreciation & amortization: 19098913.04347826
Net tangible assets: 49266304.347826086
Owner earnings: 6702173.9130434785
Capex to operating income (%): 2831.764705882353
Buffett classification: The Gruesome
Stock price: 103.29347826086956
Shares outstanding: 6407129
Book value: 204116304.34782612
P/B ratio: 3.242340890849739
Market cap (USD): 661814640.076087
Debt to equity: 1.0355136404543444
Current ratio: 1.2011415440495163
Quick ratio: 1.2011415440495163
Interest coverage ratio: 0.05929543076386466
COGS to revenue (%): 84.8227325914095
Free cash flow (dilution-adjusted): -55940217.391304344
Buyback yield (%): 0.3028563746877105
Retained earnings: 158690217.39130434
Receivables turnover: 2.1168632366855706
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.03450830736752362
FCF margin (%): -14.651999009249847
Revenue growth (%): 9.183300114144131
Rule of 40 score: -5.468698895105716
Financial ratios for ADN1.DE — quarterly report dated 2025-06-30
Total revenue: 418983529.41176474
Gross profit: 65538823.52941176
Operating income: 2570588.2352941176
Net income: -2225882.3529411764
Capital expenditures: 2064705.8823529412
Operating cash flow: -1741176.4705882354
Depreciation & amortization: 20538823.529411767
Net tangible assets: 42737647.05882353
Owner earnings: 16248235.294117648
Capex to operating income (%): 80.32036613272312
Buffett classification: The Gruesome
Stock price: 103.11764705882354
Shares outstanding: 6407129
Book value: 213392941.17647052
P/B ratio: 3.0961102238896494
Market cap (USD): 660688066.882353
Debt to equity: 1.052303400520443
Current ratio: 1.2618766450014725
Quick ratio: 1.2618766450014725
Interest coverage ratio: 0.6704510586069347
COGS to revenue (%): 84.35766111822448
Free cash flow (dilution-adjusted): -10332941.176470589
Buyback yield (%): 0
Retained earnings: 163542352.94117647
Receivables turnover: 1.8706292053387121
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.42500136156042606
FCF margin (%): -2.466192690432868
Revenue growth (%): 9.741194155377972
Rule of 40 score: 7.275001464945104
Financial ratios for ADN1.DE — quarterly report dated 2025-09-30
Total revenue: 440704705.88235295
Gross profit: 87428235.29411764
Operating income: 25752941.17647059
Net income: 14318823.529411765
Capital expenditures: 4254117.647058824
Operating cash flow: 33378823.529411767
Depreciation & amortization: 22854117.647058826
Net tangible assets: 59576470.5882353
Owner earnings: 32918823.52941177
Return on net tangible assets (%): 55.2547393364929
Capex to operating income (%): 16.51895842850617
Buffett classification: The Great
Stock price: 113.80000000000001
P/E ratio: 56.08406315537408
Shares outstanding: 6407129
Book value: 228697647.05882347
P/B ratio: 3.188188814257716
Market cap (USD): 729131280.2
Debt to equity: 0.9653022485377563
Current ratio: 1.299263122026019
Quick ratio: 1.299263122026019
Effective tax rate (%): 30.30407146538396
Interest coverage ratio: 6.605310802655401
COGS to revenue (%): 80.16171959882435
Free cash flow (dilution-adjusted): 25168235.29411765
Buyback yield (%): 0
Retained earnings: 177656470.5882353
Receivables turnover: 2.0356760516691392
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.187373986632541
FCF margin (%): 5.710906863072245
Revenue growth (%): 5.184255452973014
Rule of 40 score: 10.895162316045258
Financial ratios for ADN1.DE — annual report dated 2025-12-31
Total revenue: 1724449411.764706
Gross profit: 502356470.5882353
Operating income: 57454117.64705882
Net income: 21349411.76470588
Capital expenditures: 15272941.176470589
Operating cash flow: 100657647.05882353
Depreciation & amortization: 85894117.64705883
Net tangible assets: 30942352.94117647
Owner earnings: 91970588.23529412
Return on net tangible assets (%): 297.23204440895785
Capex to operating income (%): 26.582848718158736
Buffett classification: The Good
Stock price: 103
P/E ratio: 30.911122717253544
Shares outstanding: 6407129
Book value: 226705882.35294116
P/B ratio: 2.9109711673585883
Market cap (USD): 659934287
Debt to equity: 1.7184016606123511
Current ratio: 1.2604666222729966
Quick ratio: 1.2604666222729966
Effective tax rate (%): 52.01187335092349
Interest coverage ratio: 3.5990861522588253
COGS to revenue (%): 70.86858755258285
SG&A to revenue (%): 1.884318404783249
Free cash flow (dilution-adjusted): 50764705.88235294
Buyback yield (%): 0.32873148242801975
Retained earnings: 181497647.05882353
Receivables turnover: 6.854188878289658
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 9.37493401110725
FCF margin (%): 2.943821113917349
Revenue growth (%): 28.735788489719045
Rule of 40 score: 31.679609603636393
Financial ratios for ADN1.DE — quarterly report dated 2025-12-31
Total revenue: 449028235.2941176
Gross profit: 285771764.7058824
Operating income: 28030588.23529412
Net income: 13895294.11764706
Capital expenditures: 3290588.2352941176
Operating cash flow: 119320000
Depreciation & amortization: 21829411.76470588
Net tangible assets: 30942352.94117647
Owner earnings: 32434117.647058822
Return on net tangible assets (%): 104.8211094635185
Capex to operating income (%): 11.739276420716864
Buffett classification: The Great
Stock price: 103
P/E ratio: 35.05793725286931
Shares outstanding: 6407129
Book value: 226705882.35294116
P/B ratio: 2.9109711673585883
Market cap (USD): 659934287
Debt to equity: 1.7184016606123511
Current ratio: 1.2604666222729966
Quick ratio: 1.2604666222729966
Effective tax rate (%): 52.02832401996332
Interest coverage ratio: 5.7704044562848145
COGS to revenue (%): 36.35772937113872
Free cash flow (dilution-adjusted): 96476470.5882353
Buyback yield (%): 0
Retained earnings: 181497647.05882353
Receivables turnover: 1.7847576828834892
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.573822134258362
FCF margin (%): 21.485613376860886
Revenue growth (%): 1.8886863018854771
Rule of 40 score: 23.374299678746365
Financial ratios for AHRT — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 10.97
Shares outstanding: 75955396
Market cap (USD): 833230694.12
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AHRT — annual report dated 2022-12-31
Total revenue: 471131000
Gross profit: 171174000
Operating income: 80773000
Net income: 99953000
Capital expenditures: 0
Operating cash flow: 116858000
Depreciation & amortization: 74084000
Net tangible assets: 543580000
Owner earnings: 174037000
Return on net tangible assets (%): 32.01681445233452
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 8.79
P/E ratio: 6.6796187292027245
Shares outstanding: 75955396
Book value: 904014000
P/B ratio: 0.7385371585395801
Market cap (USD): 667647930.8399999
Debt to equity: 1.2681385465269344
Current ratio: 2.086064351566912
Quick ratio: 2.086064351566912
Effective tax rate (%): -0.14527893555626803
Interest coverage ratio: 2.035609879032258
COGS to revenue (%): 67.81404747299582
SG&A to revenue (%): 3.3304961889580604
Free cash flow (dilution-adjusted): 113585000
Buyback yield (%): 0
Retained earnings: -126875000
Receivables turnover: 1.9121429933966207
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.874549277188593
FCF margin (%): 24.109005775463725
Rule of 40 score: 24.109005775463725
Financial ratios for AHRT — annual report dated 2023-12-31
Total revenue: 253911000
Gross profit: 175050000
Operating income: 59946000
Net income: 8287000
Capital expenditures: 0
Operating cash flow: 101864000
Depreciation & amortization: 97339000
Net tangible assets: 463485000
Owner earnings: 105626000
Return on net tangible assets (%): 22.789518538895543
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 10.11
P/E ratio: 92.6642999348377
Shares outstanding: 75955396
Book value: 805178000
P/B ratio: 0.9537134069236864
Market cap (USD): 767909053.56
Debt to equity: 1.8882309253357643
Current ratio: 1.6415597358913667
Quick ratio: 1.6415597358913667
Interest coverage ratio: 1.036948624805397
COGS to revenue (%): 44.43486103398435
SG&A to revenue (%): 6.770482570664524
Free cash flow (dilution-adjusted): 98187000
Buyback yield (%): 1.6715521116065433
Retained earnings: -184724000
Receivables turnover: 0.9536635016976653
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.5376943667045833
FCF margin (%): 38.6698488840578
Revenue growth (%): -46.10607240873558
Rule of 40 score: -7.436223524677779
Financial ratios for AHRT — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 9.36
Shares outstanding: 75955396
Market cap (USD): 710942506.56
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AHRT — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 9.02
Shares outstanding: 75955396
Market cap (USD): 685117671.92
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AHRT — annual report dated 2024-12-31
Total revenue: 274068000
Gross profit: 188350000
Operating income: 78078000
Net income: 42494000
Capital expenditures: 0
Operating cash flow: 81988000
Depreciation & amortization: 90829000
Net tangible assets: 580897000
Owner earnings: 133323000
Return on net tangible assets (%): 22.95122887534279
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 9.02
P/E ratio: 16.122691954628888
Shares outstanding: 75955396
Book value: 889669000
P/B ratio: 0.7700815381001248
Market cap (USD): 685117671.92
Debt to equity: 1.5956158975978707
Current ratio: 2.0990617335369524
Quick ratio: 2.0990617335369524
Effective tax rate (%): -2.2045095504811143
Interest coverage ratio: 0.9887671753308428
COGS to revenue (%): 39.55186304128902
SG&A to revenue (%): 7.037304610534612
Free cash flow (dilution-adjusted): 76890000
Buyback yield (%): 0
Retained earnings: -218623000
Receivables turnover: 1.478188643424232
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.336679500049359
FCF margin (%): 28.055081220718947
Revenue growth (%): 7.938608410033438
Rule of 40 score: 35.993689630752385
Financial ratios for AHRT — quarterly report dated 2025-03-31
Total revenue: 50182000
Gross profit: 34096000
Operating income: 7911000
Net income: -2805000
Capital expenditures: 0
Operating cash flow: 12421000
Depreciation & amortization: 19030000
Net tangible assets: 571017000
Owner earnings: 16225000
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 6.74
Shares outstanding: 75955396
Book value: 868752000
P/B ratio: 0.589281370333536
Market cap (USD): 511939369.04
Debt to equity: 1.662976315450209
Current ratio: 3.0499078433432336
Quick ratio: 3.0499078433432336
Interest coverage ratio: 0.6360858727989065
COGS to revenue (%): 41.28771272567853
SG&A to revenue (%): 14.258100514128571
Free cash flow (dilution-adjusted): 8957000
Buyback yield (%): 0.002734698842609645
Retained earnings: -235535000
Receivables turnover: 0.1886555538011564
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.3351390142735922
FCF margin (%): 17.849029532501696
Rule of 40 score: 17.849029532501696
Financial ratios for AHRT — quarterly report dated 2025-06-30
Total revenue: 101263000
Gross profit: 48004000
Operating income: 20463000
Net income: 6717000
Capital expenditures: 0
Operating cash flow: -1211000
Depreciation & amortization: 30571000
Net tangible assets: 568513000
Owner earnings: 37288000
Return on net tangible assets (%): 6.558864968786994
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 6.3
P/E ratio: 122.32080644171778
Shares outstanding: 75955396
Book value: 860791000
P/B ratio: 0.555906131453512
Market cap (USD): 478518994.8
Debt to equity: 1.8252874391112361
Current ratio: 3.028437911890402
Quick ratio: 3.028437911890402
Effective tax rate (%): -9.21951219512195
Interest coverage ratio: 0.9620140096845471
COGS to revenue (%): 52.59472857805911
SG&A to revenue (%): 5.9231901089242855
Free cash flow (dilution-adjusted): -2573000
Buyback yield (%): 0
Retained earnings: -243695000
Receivables turnover: 0.41519777277554315
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.826279091177796
FCF margin (%): -2.5409083278196376
Revenue growth (%): 101.79147901638036
Rule of 40 score: 99.25057068856073
Financial ratios for AHRT — quarterly report dated 2025-09-30
Total revenue: 96082000
Gross profit: 51184000
Operating income: 23750000
Net income: 80000
Capital expenditures: 0
Operating cash flow: 26290000
Depreciation & amortization: 23113000
Net tangible assets: 558654000
Owner earnings: 23193000
Return on net tangible assets (%): 4.151585775811146
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 6.55
P/E ratio: 124.6262133767535
Shares outstanding: 75955396
Book value: 843639000
P/B ratio: 0.5897165064678138
Market cap (USD): 497507843.8
Debt to equity: 1.9086113847273538
Current ratio: 3.4876943303962724
Quick ratio: 3.4876943303962724
Interest coverage ratio: 1.0454265340258826
COGS to revenue (%): 61.340313482233924
SG&A to revenue (%): 4.628338294373556
Free cash flow (dilution-adjusted): 25216000
Buyback yield (%): 0
Retained earnings: -257724000
Receivables turnover: 0.3877604555525512
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.9536517231783948
FCF margin (%): 26.244249703378365
Revenue growth (%): -5.11638011909582
Rule of 40 score: 21.127869584282546
Financial ratios for AHRT — quarterly report dated 2025-12-31
Total revenue: -26787000
Gross profit: 46169000
Operating income: 20342000
Net income: 2380000
Capital expenditures: 0
Operating cash flow: 26747000
Depreciation & amortization: 23441000
Net tangible assets: 550170000
Owner earnings: 25821000
Return on net tangible assets (%): 4.693276623589073
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 6.32
P/E ratio: 75.33554656622725
Shares outstanding: 75955396
Book value: 829192000
P/B ratio: 0.5789227377012803
Market cap (USD): 480038102.72
Debt to equity: 1.9908935445590406
Current ratio: 3.325242718446602
Quick ratio: 3.325242718446602
Interest coverage ratio: 0.8763948128042738
Free cash flow (dilution-adjusted): 25802000
Buyback yield (%): 0
Retained earnings: -269484000
Receivables turnover: -0.1374749807544265
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 0.8109073456039111
Revenue growth (%): -127.87931142149414
Rule of 40 score: -127.87931142149414
Financial ratios for AHRT — annual report dated 2025-12-31
Total revenue: 285201000
Gross profit: 193189000
Operating income: 81763000
Net income: 5604000
Capital expenditures: 0
Operating cash flow: 64247000
Depreciation & amortization: 91522000
Net tangible assets: 550170000
Owner earnings: 97126000
Return on net tangible assets (%): 17.653816093207553
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 6.32
P/E ratio: 85.65990412562455
Shares outstanding: 75955396
Book value: 829192000
P/B ratio: 0.5789227377012803
Market cap (USD): 480038102.72
Debt to equity: 1.9908935445590406
Current ratio: 3.325242718446602
Quick ratio: 3.325242718446602
Interest coverage ratio: 0.9584334595411973
COGS to revenue (%): 38.94481435899594
SG&A to revenue (%): 7.132162930705012
Free cash flow (dilution-adjusted): 57402000
Buyback yield (%): 0.02791445079895261
Retained earnings: -269484000
Receivables turnover: 1.4636951501154734
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.259375543142886
FCF margin (%): 20.12685790021774
Revenue growth (%): 4.062130566136871
Rule of 40 score: 24.188988466354612
Financial ratios for AORT — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 20.35
Shares outstanding: 48543350
Market cap (USD): 987857172.5000001
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AORT — annual report dated 2022-12-31
Total revenue: 313789000
Gross profit: 202523000
Operating income: 6201000
Net income: -19094000
Capital expenditures: 10715000
Operating cash flow: -5153000
Depreciation & amortization: 22442000
Net tangible assets: -141949000
Owner earnings: -7367000
Capex to operating income (%): 172.7947105305596
Buffett classification: The Gruesome
Stock price: 12.12
Shares outstanding: 48543350
Book value: 284329000
P/B ratio: 2.069241625018904
Market cap (USD): 588345402
Debt to equity: 1.2549863010807902
Current ratio: 4.9790437845999
Quick ratio: 3.4797382989431305
Interest coverage ratio: 0.3402655838454785
COGS to revenue (%): 35.45885929717103
R&D to revenue (%): 12.390173014350408
SG&A to revenue (%): 50.17479898912964
Free cash flow (dilution-adjusted): -28212000
Buyback yield (%): 0.3050928916752204
Retained earnings: -17217000
Inventory turnover: 1.4939445205295523
Receivables turnover: 4.50949931018625
Capitalized R&D asset: 38879000
ROCI (R&D-adjusted, %): 4.271309562119959
FCF margin (%): -8.990754934048038
Rule of 40 score: -8.990754934048038
Financial ratios for AORT — annual report dated 2023-12-31
Total revenue: 354004000
Gross profit: 229176000
Operating income: -8508000
Net income: -30567000
Capital expenditures: 9752000
Operating cash flow: 18825000
Depreciation & amortization: 23076000
Net tangible assets: -137788000
Owner earnings: -17243000
Buffett classification: The Gruesome
Stock price: 17.88
Shares outstanding: 48543350
Book value: 281780000
P/B ratio: 3.080257995599404
Market cap (USD): 867955098
Debt to equity: 1.27170487614451
Current ratio: 4.850644637240331
Quick ratio: 3.4338944384915835
Interest coverage ratio: -0.33629787738645794
COGS to revenue (%): 35.26174845481972
R&D to revenue (%): 8.109230404176223
SG&A to revenue (%): 59.03238381487215
Free cash flow (dilution-adjusted): -5349000
Buyback yield (%): 0.06440425331772173
Retained earnings: -47907000
Inventory turnover: 1.5227383624475457
Receivables turnover: 4.774933232620249
Capitalized R&D asset: 54755930
ROCI (R&D-adjusted, %): -0.2951594371756771
Rosenberg metric: 0.6855371794542041
FCF margin (%): -1.510999875707619
Revenue growth (%): 12.815936823789235
Rule of 40 score: 11.304936948081616
Financial ratios for AORT — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 26.62
Shares outstanding: 48543350
Market cap (USD): 1292223977
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AORT — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 28.59
Shares outstanding: 48543350
Market cap (USD): 1387854376.5
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for AORT — annual report dated 2024-12-31
Total revenue: 388537000
Gross profit: 248781000
Operating income: 38874000
Net income: -13335000
Capital expenditures: 11188000
Operating cash flow: 22236000
Depreciation & amortization: 24205000
Net tangible assets: -121141000
Owner earnings: -318000
Capex to operating income (%): 28.780161547563925
Buffett classification: The Good
Stock price: 28.59
Shares outstanding: 48543350
Book value: 276200000
P/B ratio: 5.024816714337437
Market cap (USD): 1387854376.5
Debt to equity: 1.311578566256336
Current ratio: 4.341020307379196
Quick ratio: 3.1473295122936715
Interest coverage ratio: 1.1341132537853371
COGS to revenue (%): 35.9698046775468
R&D to revenue (%): 7.322854708817951
SG&A to revenue (%): 46.702115886003135
Free cash flow (dilution-adjusted): -3194000
Buyback yield (%): 0
Retained earnings: -61266000
Inventory turnover: 1.752074818845122
Receivables turnover: 4.523500168814688
Capitalized R&D asset: 60515760
ROCI (R&D-adjusted, %): 4.5111924925581075
Rosenberg metric: 0.6829344759117986
FCF margin (%): -0.8220581308858615
Revenue growth (%): 9.754974520061921
Rule of 40 score: 8.932916389176059
Financial ratios for AORT — quarterly report dated 2025-03-31
Total revenue: 98978000
Gross profit: 63577000
Operating income: 2145000
Net income: -504000
Capital expenditures: 3638000
Operating cash flow: -16953000
Depreciation & amortization: 5446000
Net tangible assets: -102742000
Owner earnings: 1304000
Capex to operating income (%): 169.6037296037296
Buffett classification: The Gruesome
Stock price: 24.58
Shares outstanding: 48543350
Book value: 294252000
P/B ratio: 4.055012516482471
Market cap (USD): 1193195543
Debt to equity: 1.2314580699536453
Current ratio: 5.531324605313824
Quick ratio: 3.9539853677319985
Interest coverage ratio: 0.2799164817956414
COGS to revenue (%): 35.76653397724747
R&D to revenue (%): 6.797470144880681
SG&A to revenue (%): 55.26884762270403
Free cash flow (dilution-adjusted): -28636000
Buyback yield (%): 0
Retained earnings: -61771000
Inventory turnover: 0.4321041903157689
Receivables turnover: 1.033626433300612
Capitalized R&D asset: 6728000
ROCI (R&D-adjusted, %): 0.8888430115829772
FCF margin (%): -28.931681787872055
Rule of 40 score: -28.931681787872055
Financial ratios for AORT — quarterly report dated 2025-06-30
Total revenue: 112972000
Gross profit: 73112000
Operating income: 8384000
Net income: 1345000
Capital expenditures: 3287000
Operating cash flow: 15011000
Depreciation & amortization: 5538000
Net tangible assets: 7660000
Owner earnings: 3596000
Return on net tangible assets (%): 46.945169712793735
Capex to operating income (%): 39.20562977099237
Buffett classification: The Good
Stock price: 31.1
P/E ratio: 1795.1226932223544
Shares outstanding: 48543350
Book value: 419902000
P/B ratio: 3.5953584050564182
Market cap (USD): 1509698185
Debt to equity: 0.6281013188791671
Current ratio: 4.782060896955152
Quick ratio: 3.4812809359532024
Effective tax rate (%): 61.372774267662265
Interest coverage ratio: 1.153232462173315
COGS to revenue (%): 35.283078993024816
R&D to revenue (%): 6.251991643947173
SG&A to revenue (%): 51.04362142831852
Free cash flow (dilution-adjusted): 5602000
Buyback yield (%): 0
Retained earnings: -60426000
Inventory turnover: 0.4596243211143526
Receivables turnover: 1.1157728395061728
Capitalized R&D asset: 11570760
ROCI (R&D-adjusted, %): 1.3851869713883949
Rosenberg metric: 1.4172116527942924
FCF margin (%): 4.958750840916333
Revenue growth (%): 14.138495423225365
Rule of 40 score: 19.0972462641417
Financial ratios for AORT — quarterly report dated 2025-09-30
Total revenue: 113388000
Gross profit: 74395000
Operating income: 9036000
Net income: 6502000
Capital expenditures: 4609000
Operating cash flow: 22262000
Depreciation & amortization: 5717000
Net tangible assets: 27857000
Owner earnings: 7610000
Return on net tangible assets (%): 27.31808881071185
Capex to operating income (%): 51.007082779991144
Buffett classification: The Good
Stock price: 42.34
P/E ratio: 279.9026881383631
Shares outstanding: 48543350
Book value: 438694000
P/B ratio: 4.685100409396983
Market cap (USD): 2055325439.0000002
Debt to equity: 0.597202150018008
Current ratio: 3.9318933780698075
Quick ratio: 2.877009646302251
Effective tax rate (%): 7.8514739229024935
Interest coverage ratio: 1.4767118810263116
COGS to revenue (%): 34.38900059971073
R&D to revenue (%): 7.124210674850954
SG&A to revenue (%): 50.51769146646912
Free cash flow (dilution-adjusted): 11518000
Buyback yield (%): 0
Retained earnings: -53924000
Inventory turnover: 0.43063823207836815
Receivables turnover: 1.1645184812414628
Capitalized R&D asset: 15030450
ROCI (R&D-adjusted, %): 1.248554718377581
Rosenberg metric: 0.18165085657652555
FCF margin (%): 10.158041415317317
Revenue growth (%): 0.36823283645505084
Rule of 40 score: 10.526274251772367
Financial ratios for AORT — annual report dated 2025-12-31
Total revenue: 441330000
Gross profit: 284227000
Operating income: 26745000
Net income: 9768000
Capital expenditures: 39041000
Operating cash flow: 39880000
Depreciation & amortization: 22458000
Net tangible assets: 37646000
Owner earnings: -6815000
Return on net tangible assets (%): -18.10285289273761
Capex to operating income (%): 145.97494858852122
Buffett classification: The Gruesome
Stock price: 45.61
P/E ratio: 226.66484372440624
Shares outstanding: 48543350
Book value: 448232000
P/B ratio: 4.939545131762123
Market cap (USD): 2214062193.5
Debt to equity: 0.5747336200895965
Current ratio: 3.5259561227303164
Quick ratio: 2.615847414234511
Effective tax rate (%): 33.910690121786196
Interest coverage ratio: 1.00613196900158
COGS to revenue (%): 35.597625359708154
R&D to revenue (%): 7.0221829470011095
SG&A to revenue (%): 51.32010060498946
Free cash flow (dilution-adjusted): -23546000
Buyback yield (%): 0
Retained earnings: -51498000
Inventory turnover: 1.6997522369004727
Receivables turnover: 4.256696148689706
Capitalized R&D asset: 59527150
ROCI (R&D-adjusted, %): 3.364234909567449
Rosenberg metric: 1.2458175172219879
FCF margin (%): -5.3352366709718355
Revenue growth (%): 13.58763772819577
Rule of 40 score: 8.252401057223935
Financial ratios for AORT — quarterly report dated 2025-12-31
Total revenue: 115992000
Gross profit: 73143000
Operating income: 7180000
Net income: 2426000
Capital expenditures: 27507000
Operating cash flow: 19560000
Depreciation & amortization: 5757000
Net tangible assets: 37646000
Owner earnings: -19324000
Return on net tangible assets (%): -51.33081867927536
Capex to operating income (%): 383.1058495821727
Buffett classification: The Gruesome
Stock price: 45.61
P/E ratio: 226.64164126317942
Shares outstanding: 48543350
Book value: 448232000
P/B ratio: 4.939545131762123
Market cap (USD): 2214062193.5
Debt to equity: 0.5747336200895965
Current ratio: 3.5259561227303164
Quick ratio: 2.615847414234511
Effective tax rate (%): 62.88817500382439
Interest coverage ratio: 1.298372513562387
COGS to revenue (%): 36.94134078212291
R&D to revenue (%): 7.864335471411822
SG&A to revenue (%): 49.00424167183944
Free cash flow (dilution-adjusted): -12030000
Buyback yield (%): 0
Retained earnings: -51498000
Inventory turnover: 0.4635982991982862
Receivables turnover: 1.118760790516884
Capitalized R&D asset: 16865050
ROCI (R&D-adjusted, %): 1.0266568537885534
Rosenberg metric: -0.15498885862837336
FCF margin (%): -10.37140492447755
Revenue growth (%): 2.29653931632977
Rule of 40 score: -8.07486560814778
Financial ratios for ARCM.L — annual report dated 2021-12-31
Total revenue: 0
Operating income: -7629729.72972973
Net income: -7241891.891891892
Capital expenditures: 0
Operating cash flow: -4836486.486486486
Depreciation & amortization: 41891.89189189189
Net tangible assets: 9348648.64864865
Owner earnings: -7200000
Return on net tangible assets (%): -77.01647875108412
Buffett classification: The Gruesome
Stock price: 0.0002702702702702703
Shares outstanding: 2459587314
Book value: 11056756.756756756
P/B ratio: 0.06012190941090198
Market cap (USD): 664753.3281081081
Debt to equity: 0.44072353947690057
Current ratio: 7.27727952167414
Quick ratio: 7.27727952167414
Free cash flow (dilution-adjusted): -5363513.513513514
Buyback yield (%): 0
Retained earnings: -72141891.8918919
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -43.7301525830687
Rule of 40 score: 0